Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 201,644 | 183,898 | 317,823 | 231,619 | 255,505 |
| Depreciation Amortization | 94,654 | 105,049 | 114,130 | 112,684 | 85,481 |
| Income taxes - deferred | -18,337 | -29,465 | -37,048 | -5,274 | -40,191 |
| Accounts receivable | 47,779 | -14,314 | -49,034 | 1,251 | -27,492 |
| Other Working Capital | -41,998 | -56,254 | -24,638 | -100,417 | -61,176 |
| Other Operating Activity | 83,339 | 129,662 | 126,520 | 103,986 | 115,547 |
| Operating Cash Flow | $367,081 | $318,576 | $447,753 | $343,849 | $327,674 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30,339 | -47,928 | -38,089 | -66,347 | -96,281 |
| Net Acquisitions | 25,703 | -38,171 | -4,500 | N/A | -14,919 |
| Purchase Of Investment | -172,955 | -316,313 | -67,101 | -287,777 | -265,361 |
| Sale Of Investment | 231,797 | 118,005 | 64,785 | 491,138 | 337,587 |
| Purchase Sale Intangibles | N/A | -11,528 | N/A | -2,640 | -17,255 |
| Other Investing Activity | 0 | -11,528 | 0 | -2,640 | -17,255 |
| Investing Cash Flow | $54,206 | $-295,935 | $-44,905 | $134,374 | $-56,229 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 47,781 | 57,848 | 122,088 | 82,658 | 57,346 |
| Common Stock Repurchased | -149,276 | -530,486 | -245,864 | -173,742 | -340,585 |
| Dividend Paid | -103,407 | -100,067 | -89,172 | -88,581 | -77,496 |
| Other Financing Activity | -31,910 | -37,853 | -39,567 | -28,110 | -24,546 |
| Financing Cash Flow | $-236,812 | $-610,558 | $-252,515 | $-207,775 | $-385,281 |
| Exchange Rate Effect | 5,120 | -16,744 | 2,720 | 3,938 | -5,821 |
| Beginning Cash Position | 628,371 | 1,233,032 | 1,079,979 | 805,593 | 925,250 |
| End Cash Position | 817,966 | 628,371 | 1,233,032 | 1,079,979 | 805,593 |
| Net Cash Flow | $189,595 | $-604,661 | $153,053 | $274,386 | $-119,657 |
| Free Cash Flow | |||||
| Operating Cash Flow | 367,081 | 318,576 | 447,753 | 343,849 | 327,674 |
| Capital Expenditure | -30,339 | -47,928 | -54,454 | -66,347 | -96,281 |
| Free Cash Flow | 336,742 | 270,648 | 393,299 | 277,502 | 231,393 |